TMCnet News

Research and Markets: Global Lung Cancer Pipeline Review 2015
[November 27, 2015]

Research and Markets: Global Lung Cancer Pipeline Review 2015


Research and Markets (http://www.researchandmarkets.com/research/737n6x/lung_cancer) has announced the addition of the "Lung Cancer - Pipeline Review, 2015" report to their offering.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Lung Cancer diagnostic tests pipeline products.

Scope

  • Extensive coverage of the Lung Cancer diagnostic tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Lung Cancer diagnostic tests and list all their pipeline projects
  • The coveage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry



Key Topics Covered:

1 Tables & Figures


2 Introduction

3 Products under Development

4 Lung Cancer - Pipeline Products under Development by Companies

5 Lung Cancer Companies and Product Overview

6 Lung Cancer- Recent Developments

7 Appendix

Companies Mentioned - 35 of the 100+ Companies

  • A&G Pharmaceutical, Inc.
  • Advpharma Inc.
  • Ceres Nanosciences, Inc.
  • Cernostics Inc.
  • ChemImage Corporation
  • Chronix Biomedical, Inc.
  • Clarient, Inc.
  • GenomicTree, Inc.
  • GILUPI Nanomedizin
  • Global Discovery Biosciences
  • GlycoZym
  • HTG Molecular Diagnostics, Inc.
  • ImmunoCellular Therapeutics, Ltd.
  • Insight Genetics, Inc.
  • MolecularMD, Corp.
  • Nanopore Diagnostics, LLC
  • Neogenix Oncology, Inc.
  • NEOMICS Co., Ltd.
  • Novel Bio-spectrum Technologies, Inc.
  • Nuvera Biosciences, Inc.
  • Oncolome Diagnostics Inc.
  • Onconome, Inc.
  • OPKO Health, Inc.
  • Orion Genomics LLC
  • OTraces Inc.
  • Oxford Gene Technology Limited
  • PeriRx LLC
  • US Biomarkers, Inc.
  • Ventana Medical Systems, Inc.
  • Veracyte, Inc.
  • Vigilant Biosciences, Inc.
  • Viomics Inc.
  • VisionGate, Inc.
  • Vitatex Inc.
  • VolitionRX Ltd.

For more information visit http://www.researchandmarkets.com/research/737n6x/lung_cancer


[ Back To TMCnet.com's Homepage ]